Intervention

123-I-MIP-1072

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

2 shown

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate CancerNCT00992745 · 2009-10-01

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsNCT00712829 · 2008-05-01

Common conditions

Prostate Cancer2

Leading sponsors

Molecular Insight Pharmaceuticals, Inc.2

Trial status mix

COMPLETED2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.